The conjugates of 5'-deoxy-5-fluorocytidine and hydroxycinnamic acids - synthesis, anti-pancreatic cancer activity and molecular docking studies.


Journal

RSC advances
ISSN: 2046-2069
Titre abrégé: RSC Adv
Pays: England
ID NLM: 101581657

Informations de publication

Date de publication:
22 Apr 2024
Historique:
received: 04 03 2024
accepted: 15 04 2024
medline: 24 4 2024
pubmed: 24 4 2024
entrez: 24 4 2024
Statut: epublish

Résumé

New amide conjugates 1-6 of hydroxycinnamic acids (HCA) and 5'-deoxy-5-fluorocytidine (5-dFCR), the prodrug of 5-fluorouracil (5-FU), were synthesized and tested

Identifiants

pubmed: 38655481
doi: 10.1039/d4ra01683a
pii: d4ra01683a
pmc: PMC11036175
doi:

Types de publication

Journal Article

Langues

eng

Pagination

13129-13141

Informations de copyright

This journal is © The Royal Society of Chemistry.

Déclaration de conflit d'intérêts

There are no conflicts to declare.

Références

Nucleic Acids Res. 2023 Jan 6;51(D1):D1373-D1380
pubmed: 36305812
JAMA Oncol. 2022 Mar 01;8(3):420-444
pubmed: 34967848
Oncotarget. 2017 Jun 6;8(23):38022-38043
pubmed: 28410237
JCO Precis Oncol. 2020 Nov;4:426-436
pubmed: 35050739
J Med Chem. 2003 Jul 17;46(15):3275-82
pubmed: 12852757
Acta Pharm Sin B. 2018 Sep;8(5):699-712
pubmed: 30245959
Cancer Med. 2015 Sep;4(9):1394-403
pubmed: 26177855
Biomedicines. 2022 Feb 24;10(3):
pubmed: 35327333
Eur J Med Chem. 2019 Nov 1;181:111587
pubmed: 31404864
ChemMedChem. 2018 Sep 19;13(18):1972-1977
pubmed: 30044536
J Comb Chem. 2004 Sep-Oct;6(5):695-8
pubmed: 15360202
Molecules. 2023 Mar 01;28(5):
pubmed: 36903533
Eur J Cancer. 2018 Nov;103:356-387
pubmed: 30100160
J Pept Sci. 2006 May;12(5):369-75
pubmed: 16331636
J Comput Chem. 2009 Dec;30(16):2785-91
pubmed: 19399780
Int J Mol Sci. 2023 Feb 01;24(3):
pubmed: 36769117
J Clin Oncol. 1998 Jan;16(1):301-8
pubmed: 9440757
Chem Biol. 2014 Sep 18;21(9):1115-42
pubmed: 25237858
Bioorg Med Chem Lett. 2015 Nov 1;25(21):4843-4847
pubmed: 26152427
Integr Cancer Ther. 2018 Sep;17(3):619-627
pubmed: 29614889
J Immunol Methods. 1983 Dec 16;65(1-2):55-63
pubmed: 6606682
J Mol Biol. 2005 Oct 14;353(1):38-52
pubmed: 16169013
World J Gastroenterol. 2019 Feb 21;25(7):789-807
pubmed: 30809080
Bioconjug Chem. 2014 Dec 17;25(12):2189-96
pubmed: 25405515
Nature. 2021 Aug;596(7873):583-589
pubmed: 34265844
Saudi J Biol Sci. 2022 May;29(5):3704-3716
pubmed: 35844373
Oncol Rep. 2015 Dec;34(6):3304-10
pubmed: 26397991
Materials (Basel). 2020 Dec 19;13(24):
pubmed: 33352809
Cancers (Basel). 2010 Sep 17;2(3):1717-30
pubmed: 24281184
J Comput Chem. 2010 Jan 30;31(2):455-61
pubmed: 19499576
Pharmaceuticals (Basel). 2022 Dec 30;16(1):
pubmed: 36678550
Bioorg Med Chem. 2018 Feb 1;26(3):543-550
pubmed: 29310862
Molecules. 2021 Sep 27;26(19):
pubmed: 34641391
Nat Rev Drug Discov. 2021 Aug;20(8):583-584
pubmed: 33762691
Food Chem. 2013 Jun 15;138(4):2079-88
pubmed: 23497861
Bioorg Chem. 2019 Sep;90:103037
pubmed: 31212179
Front Oncol. 2019 Jun 21;9:541
pubmed: 31293975
Eur J Med Chem. 2019 Sep 1;177:259-268
pubmed: 31158743
Invest New Drugs. 2013 Dec;31(6):1409-23
pubmed: 23959266
Cancers (Basel). 2019 Dec 09;11(12):
pubmed: 31835393
Bioorg Med Chem Lett. 2001 Jan 22;11(2):215-7
pubmed: 11206462
Eur J Med Chem. 2012 Aug;54:690-6
pubmed: 22796042
Clin Ther. 2009;31 Pt 2:2273-89
pubmed: 20110041
Molecules. 2021 Apr 29;26(9):
pubmed: 33946916
Front Pharmacol. 2019 May 09;10:507
pubmed: 31143124
Curr Drug Metab. 2019;20(2):91-102
pubmed: 30129408
Nature. 2006 Mar 23;440(7083):463-9
pubmed: 16554806
Front Chem. 2022 May 26;10:889083
pubmed: 35720996
Clin Cancer Res. 2022 Jan 15;28(2):368-377
pubmed: 35045958
Int J Mol Sci. 2023 May 17;24(10):
pubmed: 37240221
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Dalton Trans. 2020 Jan 28;49(4):1207-1219
pubmed: 31903475
Mol Metab. 2022 Feb;56:101426
pubmed: 34971802
Nucleic Acids Res. 2018 Jul 2;46(W1):W257-W263
pubmed: 29718510
Bioorg Med Chem. 2000 Jul;8(7):1697-706
pubmed: 10976516
Bioorg Med Chem Lett. 2010 Dec 15;20(24):7205-11
pubmed: 21071221
Int J Mol Sci. 2024 Feb 22;25(5):
pubmed: 38473820
Bioact Mater. 2020 Oct 24;6(4):1163-1174
pubmed: 33134609
J Agric Food Chem. 2000 Jun;48(6):2101-10
pubmed: 10888506

Auteurs

Marcin Cybulski (M)

Pharmacy, Cosmetic Chemistry and Biotechnology Research Group, Łukasiewicz Research Network-Industrial Chemistry Institute Rydygiera 8 01-793 Warsaw Poland olga.michalak@ichp.lukasiewicz.gov.pl marcin.cybulski@ichp.lukasiewicz.gov.pl +48 453 056 175 +48 453 056 177.

Magdalena Zaremba-Czogalla (M)

Department of Lipids and Liposomes, Faculty of Biotechnology, University of Wroclaw Fryderyka Joliot-Curie 14a 50-383 Wroclaw Poland.

Bartosz Trzaskowski (B)

Chemical and Biological Systems Simulation Laboratory, Center of New Technologies, University of Warsaw Banacha 2c 02-097 Warsaw Poland.

Marek Kubiszewski (M)

Pharmaceutical Analysis Laboratory, Łukasiewicz Research Network-Industrial Chemistry Institute Rydygiera 8 01-793 Warsaw Poland.

Joanna Tobiasz (J)

Pharmacy, Cosmetic Chemistry and Biotechnology Research Group, Łukasiewicz Research Network-Industrial Chemistry Institute Rydygiera 8 01-793 Warsaw Poland olga.michalak@ichp.lukasiewicz.gov.pl marcin.cybulski@ichp.lukasiewicz.gov.pl +48 453 056 175 +48 453 056 177.

Anna Jaromin (A)

Department of Lipids and Liposomes, Faculty of Biotechnology, University of Wroclaw Fryderyka Joliot-Curie 14a 50-383 Wroclaw Poland.

Piotr Krzeczyński (P)

Pharmacy, Cosmetic Chemistry and Biotechnology Research Group, Łukasiewicz Research Network-Industrial Chemistry Institute Rydygiera 8 01-793 Warsaw Poland olga.michalak@ichp.lukasiewicz.gov.pl marcin.cybulski@ichp.lukasiewicz.gov.pl +48 453 056 175 +48 453 056 177.

Jerzy Gubernator (J)

Department of Lipids and Liposomes, Faculty of Biotechnology, University of Wroclaw Fryderyka Joliot-Curie 14a 50-383 Wroclaw Poland.

Olga Michalak (O)

Pharmacy, Cosmetic Chemistry and Biotechnology Research Group, Łukasiewicz Research Network-Industrial Chemistry Institute Rydygiera 8 01-793 Warsaw Poland olga.michalak@ichp.lukasiewicz.gov.pl marcin.cybulski@ichp.lukasiewicz.gov.pl +48 453 056 175 +48 453 056 177.

Classifications MeSH